🇮🇳IN
Sign In
SH

SHUKRAMED

NSE

Shukra Medtech Ltd

₹82.17

-0.03(-0.04%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

SHUKRAMED valuation summary

The median P/E across 101 listed Drug Manufacturers - Specialty & Generic companies is 33.4, so Shukra Medtech Ltd trades at a 144% premium to that median.

ROCE37.0%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer